The splice variant LOXIN inhibits LOX-1 receptor function through hetero-oligomerization

Journal of Molecular and Cellular Cardiology

Volumn 44, Issue 3, 2008, Pages 561-570

  Biocca, Silvia ^a   Filesi, Ilaria ^a   Mango, Ruggiero ^a   Maggiore, Luana ^a   Baldini, Francesco ^a   Vecchione, Lucia ^b   Viola, Antonella ^b   Citro, Gennaro ^c   Federici, Giorgio ^a   Romeo, Francesco ^a,d   Novelli, Giuseppe ^b,d  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Department of Surgery   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Lectin like oxidized LDL receptor (LOX 1); LOXIN; oligomerization; oxidized LDL

Indexed keywords

LOXIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HEART INFARCTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIGAND BINDING; MOLECULAR CLONING; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN VARIANT; RECEPTOR BINDING;

MAMMALIA;

EID: 40649099556     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.11.017     Document Type: Article

References (30)

1. Binder CJ, Chang MK, Shaw PX, Miller YI, Hartvigsen K, Dewan A, et al.Innate and acquired immunity in atherogenesis. Nat Med 2002;8:1218–1226
2. Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 2002;8:1211–7.
3. Chen M, Masaki T, Sawamura T. LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. Pharmacol Ther 2002;95:89–100.
4. Metha JL, Chen J, Hermonat P, Romeo F, Novelli G. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovascular Research 2006;69(1),pp:36–45.
5. Ehara S, Ueda M, Naruko T, Haze K, Itoh A, Otsuka M, et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 2001;103: 1955–60.
6. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, et al. An endothelial receptor for oxidized low-density lipoprotein.Nature 1997;386:73–7.
7. Chen M, Narumiya S, Masaki T, Sawamura T. Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for the oxidized low-density-lipoprotein binding. Biochem J 2001;355:289–96.
8. Xie Q, Matsunaga S, Shi X, Ogawa S, Niimi S,Wen Z, et al. Refolding and characterization of the functional ligand-binding domain of human lectinlike oxidized LDL receptor. Protein Expr Purif 2003;32:68–74
9. Xie Q, Matsunaga S, Niimi S, Ogawa S, Tokuyasu K, Sakakibara Y, et al. Human lectin-like oxidized low-density lipoprotein receptor-1 functions as a dimer in living cells. DNA Cell Biol 2004;23:111–7
10. Ohki I, Ishigaki T, Oyama T, Matsunaga S, Xie Q, Ohnishi-Kameyama M, et al. Crystal structure of human lectin-like, oxidized low-density lipoprotein receptor-1 ligand binding domain and its ligand recognition mode to ox-LDL. Structure 2005;13:905–17..
11. Park H, Adsit FG, Boyington JC. The 1.4 angstrom crystal structure of the human oxidized low density lipoprotein receptor lox-1. J Biol Chem 2005;280:13593–9.
12. Vohra RS, Murphy JE, Walker JH, Ponnambalam S, Vanniasinkam SH. Atherosclerosis and the lectin-like oxidized low-density lipoprotein scavenger receptor. Trends Cardiovasc Med 2006;16:60–4.
13. Mango R, Clementi F, Borgiani P, Forleo GB, Federici M, Contino G, et al. Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction. J Med Genet 2003;40:933–6.
14. Chen Q, Reis SE, Kammerer C, Craig WY, LaPierre SE, Zimmer EL, et al.Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1(LOX1) gene and the risk of coronary artery disease. Circulation 2003;107:3146–51.
15. Mango R, Biocca S, Del Vecchio F, Clementi F, Sangiuolo F, Amati F, et al. In vivo and in vitro studies supports that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction. Circ Res 2005;97:152–8..
16. Lener M, Horn IR, Cardinale A, Messina S, Nielsen UB, Rybak SM, et al. Diverting a protein from its cellular location by intracellular antibodies. The case of p21Ras. Eur J Biochem 2000;267:1196–205.
17. Cardinale A, Filesi I, Vetrugno V, Pocchiari M, Sy MS, Biocca S. Trapping prion protein in the endoplasmic reticulum impairs PrPc maturation and prevents PrPSc accumulation. J Biol Chem 2005;280:685–94.
18. Smith DB, Johnson KS. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 1988;67:31–40.
19. Tentori L, Vergati M, Muzi A, Levati L, Ruffini F, Forini O. Generation of an immortalized human endothelial cell line as a model of neovascular proliferating endothelial cells to assess chemosensitivity to anticancer drugs. International Journal of Oncology 27(2),2005;pp:525–535.
20. Yuan XM, Brunk UT, Olsson AG. Effects of iron- and haemoglobinloaded human monocyte derived macrophages on oxidation and uptake of LDL. Arterioscler Thromb Vasc Biol 1995;15:1345–51.
21. Sattler W, Bone P, Stocker R. Isolation of human VLDL, LDL, HDL and two HDL subclasses in the TL-100 tabletop centrifuge using the TLA- 100.4 rotor. Technical information Beckman; 1992.
22. Stephan ZF, Yurachek EC. Rapid fluorometric assay of LDL receptor activity by DiI-labeled LDL. J Lipid Res 1993;34:325–30.
23. Li D,Williams V, Liu L, Chen H, Sawamura T, Romeo F, et al. Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia– reperfusion and its role in determination of apoptosis and left ventricular dysfunction. J Am Coll Cardiol 2003;41:1048–55.
24. Shi X, Niimi S, Ohtani T, Machida S. Characterization of residues and sequences of the carbohydrate recognition domain required for cell surface localization and ligand binding of human lectin-like oxidized LDL receptor. J Cell Sci 2001;114:1273–82.
25. Bulenger S, Marullo S, Bouvier M. Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends Pharmacol Sci 2005;26:131–7.
26. Matsunaga S, Xie Q, Kumanu M, Niimi S, Sekizawa K, Sakakibara Y,et al. Lectin-like oxidized low-density lipoprotein receptor (LOX-1) functions as an oligomer and oligomerization is dependent on receptor density. Exp Cell Res 2007;313:1203–14.
27. Feng YH, Li X, Wang L, Zhou L, Gorodeski GI. A truncated P2X7 receptor variant (P2X 7-J) endogenously expressed in cervical cancer cells antagonizes the full-length P2X7 receptor through hetero-oligomerization. J Biol Chem 2005;281:17228–37
28. Tanigawa H, Miura S, Matsuo Y, Fujino M, Sawamura T, Saku K. Dominant-negative Lox-1 blocks homodimerization of wild-type Lox-1- induced cell proliferation through extracellular signal regulated kinase 1/2 activation. Hypertension 2006;48:294–300.
29. Knight JC. Regulatory polymorphisms underlying complex disease traits.J Mol Med 2005;83:97–109.
30. Mehta JL, Sanada N, Hu CP, Chen J, Dandapat A, Sugawara F, et al.Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet. Circ Res 2007;100:1634–42.